BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3311466)

  • 1. A latex agglutination assay for D dimer: evaluation and application to the diagnosis of thrombotic disease.
    Hillyard CJ; Blake AS; Wilson K; Rylatt DB; Miles S; Bunch R; Elms MJ; Barnes A; Bundesen PG
    Clin Chem; 1987 Oct; 33(10):1837-40. PubMed ID: 3311466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody-coated latex particles.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Am J Clin Pathol; 1986 Mar; 85(3):360-4. PubMed ID: 2875646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
    Greenberg CS; Devine DV; McCrae KM
    Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of a latex test for determining the fibrinogen/fibrin D-dimer (XDP)].
    Barsotti A; Savarino A
    Quad Sclavo Diagn; 1987 Dec; 23(4):421-4. PubMed ID: 3508302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The simpliRED D dimer test: a novel assay for the detection of crosslinked fibrin degradation products in whole blood.
    John MA; Elms MJ; O'Reilly EJ; Rylatt DB; Bundesen PG; Hillyard CJ
    Thromb Res; 1990 May; 58(3):273-81. PubMed ID: 2191471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new anti-fibrinogen-coated latex particle agglutination test in the measurement of serum fibrin degradation products.
    Marder VJ; Cruz GO; Schumer BR
    Thromb Haemost; 1977 Apr; 37(2):183-91. PubMed ID: 577622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of D dimer assays for the diagnosis of deep vein thrombosis.
    Heaton DC; Billings JD; Hickton CM
    J Lab Clin Med; 1987 Nov; 110(5):588-91. PubMed ID: 3312443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of whole blood D-dimer test to plasma D-dimer test for diagnosis of disseminated intravascular coagulation.
    Gupta PK; Gupta M; Chatterjee T; Saxena R
    Indian J Exp Biol; 2005 Apr; 43(4):382-4. PubMed ID: 15875726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of a latex agglutination assay for FDP D-dimer to demonstrate the presence of postmortem blood.
    Sakurada K; Sakai I; Sekiguchi K; Shiraishi T; Ikegaya H; Yoshida K
    Int J Legal Med; 2005 May; 119(3):167-71. PubMed ID: 15654628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum D dimer: a degradation product of cross-linked fibrin (XDP) after intravenous streptokinase during acute myocardial infarction.
    Lew AS; Berberian L; Cercek B; Lee S; Shah PK; Ganz W
    J Am Coll Cardiol; 1986 Jun; 7(6):1320-4. PubMed ID: 3711489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of D-Dimer assay by enzyme immunoassay and latex agglutination techniques in the diagnosis of deep vein thrombosis.
    Chapman CS; Akhtar N; Campbell S; Miles K; O'Connor J; Mitchell VE
    Clin Lab Haematol; 1990; 12(1):37-42. PubMed ID: 2188775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of cross linked fibrin degradation products in thrombotic disorders].
    Koyama T; Oura Y; Higuchi M; Kakishita E; Nagai K
    Rinsho Ketsueki; 1989 May; 30(5):659-62. PubMed ID: 2677436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of a new latex photometric immunoassay reagent, LPIA-GENESIS D-dimer, and its performance in patient-derived plasma samples.
    Nagahama Y; Nozaki J; Sakurai G; Yajima S; Kaneko N; Yamazaki E; Matsuda M
    Int J Lab Hematol; 2020 Jun; 42(3):299-307. PubMed ID: 32112525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of fibrinogen and cross-linked fibrin by human neutrophil elastase generates D-like fragments detected by ELISA but not latex D-dimer test.
    Bach-Gansmo ET; Godal HC; Skjønsberg OH
    Thromb Res; 1998 Nov; 92(3):125-34. PubMed ID: 9806364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the fibrin D-dimer in screening for coagulation abnormalities in preeclampsia.
    Trofatter KF; Howell ML; Greenberg CS; Hage ML
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):435-40. PubMed ID: 2915868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to different neo-epitopes on fibrinogen and fibrin degradation products.
    Amiral J; Grosley M; Mimilla F; Plassart V; Chambrette B
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):447-52. PubMed ID: 1723302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of FDP in human plasma by a novel latex immunoassay.
    Sakai Y; Maeda M; Takei F; Matsumoto T; Nishijima Y; Nakamura K
    Thromb Res; 1988 May; 50(4):469-79. PubMed ID: 3413715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated determination of cross-linked fibrin derivatives in plasma.
    Elms MJ; Bundesen PG; Rowbury D; Goodall S; Wakeham N; Rowell JA; Hillyard CJ; Rylatt DB
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):159-64. PubMed ID: 8457646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A latex immunoassay of fibrin/fibrinogen degradation products in plasma using a monoclonal antibody.
    Mirshahi M; Soria J; Soria C; Perrot JY; Boucheix C
    Thromb Res; 1986 Dec; 44(6):715-28. PubMed ID: 3798417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of D dimer in patients with elevated fibrinogen degradation products in serum: further study in chronic myelogenous leukemia.
    Saito M; Asakura H; Jokaji H; Uotanzi C; Kumabashiri I; Yoshida T; Hashizume K; Matsuda T
    Acta Haematol; 1990; 84(3):149-55. PubMed ID: 2123066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.